Transaction Date | Recipient | Shares | Type | Price | Value |
---|---|---|---|---|---|
21st August 2020 | Holding, S.A. Biodyne | 75,000 | Open or private sale | $0.38 | $28,500.00 |
20th August 2020 | Holding, S.A. Biodyne | 75,000 | Open or private sale | $0.27 | $20,250.00 |
19th August 2020 | Holding, S.A. Biodyne | 50,000 | Open or private sale | $0.30 | $15,000.00 |
18th August 2020 | Holding, S.A. Biodyne | 50,000 | Open or private sale | $0.34 | $17,000.00 |
14th August 2020 | Holding, S.A. Biodyne | 50,000 | Open or private sale | $0.31 | $15,500.00 |
3rd August 2020 | Holding, S.A. Biodyne | 70,000 | Open or private sale | $0.32 | $22,400.00 |
31st July 2020 | Holding, S.A. Biodyne | 5,000 | Open or private sale | $0.34 | $1,700.00 |
30th July 2020 | Holding, S.A. Biodyne | 25,000 | Open or private sale | $0.32 | $8,000.00 |
21st July 2020 | Holding, S.A. Biodyne | 50,000 | Open or private sale | $0.45 | $22,500.00 |
20th July 2020 | Holding, S.A. Biodyne | 150,000 | Open or private sale | $0.43 | $64,500.00 |
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.
Hancock Jaffe Laboratories, Inc. is a development stage medical device company. Its products include The Bioprosthetic Heart Valve, The CoreoGraft, and The Venous Valve.